logo
  • Home
  • News
Menu

Sanofi to buy mRNA developer for $3.2 billion

Home / Stock Analysis / Sanofi to buy mRNA developer for $3.2 billion
Article feature image

Sanofi to buy mRNA developer for $3.2 billion

03 Aug Stock Analysis

Shares of Translate Bio Inc.
TBIO,
+5.46%
soared 29.8% in premarket trading on Tuesday after Sanofi
fr:snySNY,
+0.08%
said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were…

Click here to view the original article.

Tags:
featured, Global, MarketWatch
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

4ede54afa2108a12bdee07c0b0d94a59.jpeg
+

Has The Recent 37% HP (HPQ) Share Price Slump Created An Opportunity?

01 Feb Stock Analysis
4c880d91609e495c17f244eb3774e6f7e006ea2c-1920x1079.jpg
+

Michael Saylor’s bitcoin stack is officially underwater, but here’s why he likely won’t reach for the panic button

01 Feb Stock Analysis

recent post

  • 108239359-1765316609703-gettyimages-2250342442-US_CRYPTO.jpeg

    Bitcoin dips below $79,000 after silver

    Feb 01 2026
  • 4ede54afa2108a12bdee07c0b0d94a59.jpeg

    Has The Recent 37% HP (HPQ)

    Feb 01 2026
  • https3A2F2Fsubstack-post-media.s3.amazonaws.com2Fpublic2Fimages2F5ec45338-9026-4698-8287-4718d.jpeg

    Russia’s Proposed Crypto Regulations Slated to

    Feb 01 2026
  • 4c880d91609e495c17f244eb3774e6f7e006ea2c-1920x1079.jpg

    Michael Saylor’s bitcoin stack is officially

    Feb 01 2026
  • 973449623e2c3e5157567bc78dd321f9.jpeg

    SEC Chair Atkins Says ‘The Time

    Feb 01 2026

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.